Evoqua Water Technologies, a critical water and wastewater treatment solutions company, recently completed the purchase of a kidney business operated by Mar Cor Purification and Cantel Medical.
The purchase helps Evoqua expand its reach into the vertical healthcare market.
Based in Minnesota, Mar Cor, a subsidiary of STERIS, is a manufacturer and supplier of medical water, commercial and industrial solutions. It operates 27 service and reclamation facilities in the United States and Canada and designs, builds and maintains water treatment systems for an installed base of approximately 5,500 sites.
Evoqua expects the purchase to generate annualized revenue of approximately $ 180 million and adjusted earnings before interest, taxes, depreciation, and amortization of approximately $ 27 million.
“We are delighted to officially welcome Mar Cor to the Evoqua family,” said Ron Keating, CEO of Evoqua. “With the closing of this transaction, Evoqua is well positioned to expand our service footprint in North America to provide proven water solutions for the healthcare industry. ”
Based in Pittsburgh, Evoqua Water Technologies is over 100 years old. It serves more than 38,000 customers and 200,000 installations worldwide and operates in more than 150 sites in ten countries.
The company offers a broad portfolio of products, services and expertise to support industrial, municipal and recreational customers.